Point72 Asia (Singapore) Pte. Ltd. Chroma Dex Corp. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 60,691 shares of CDXC stock, worth $154,155. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,691Holding current value
$154,155% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
71Shares Held
13.1MCall Options Held
97.1KPut Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA3.05MShares$7.74 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA3.02MShares$7.68 Million5.51% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$3.29 Million0.08% of portfolio
-
Black Rock Inc. New York, NY903KShares$2.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny584KShares$1.48 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $174M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...